Related Experiment Videos
Anti-endothelial cell reactivity, the unresolved enigma.
S Castillo1, R Revelen, A Bordron
1Lab. of Immunology, Brest University Medical School, Brest, France.
International Journal of Immunopathology and Pharmacology
|February 27, 2003
Summary
Some anti-endothelial cell antibodies (AECA) target unknown structures and induce cell death. These antibodies are pathogenic, as demonstrated in a mouse model of vasculitis.
Area of Science:
- Immunology
- Vascular Biology
- Autoimmunity
Background:
- Anti-endothelial cell antibodies (AECA) are implicated in various conditions.
- The precise targets and functions of AECA are not fully understood.
Purpose of the Study:
- To elucidate the diverse targets and pathogenic mechanisms of AECA.
- To highlight the role of AECA in inducing endothelial cell apoptosis and vasculitis.
Main Methods:
- Analysis of AECA binding to cell membrane structures and "planted" antigens.
- Functional assays assessing complement activation, antibody-dependent cell cytotoxicity, and procoagulant factor production.
- Induction of apoptosis by AECA.
- Utilizing an autoantibody-induced murine model of vasculitis.
Main Results:
- AECA target unidentified cell membrane structures, "planted" antigens, and ligand-receptor complexes.
- AECA exhibit functional heterogeneity, including complement activation, cytotoxicity, and procoagulant activity.
- A subset of AECA induces apoptosis in target endothelial cells.
- The autoantibody-induced murine model confirms AECA pathogenicity in vasculitis.
Conclusions:
- AECA possess diverse targets and exert multiple pathogenic functions.
- AECA-induced apoptosis and procoagulant activity contribute to vascular inflammation.
- AECA are directly pathogenic, playing a critical role in the development of vasculitis.